Personalised care for stroke patients

More than 1,000 North Tyneside residents at increased risk of stroke are to benefit from a personalised treatment plan.

Monday, 3rd June 2019, 11:20 am
NHS news.

Health bosses in the borough have secured a share of a new £9m programme led by NHS England.

Under the scheme, those at higher risk of experiencing a stroke will receive targeted checks and treatment, which can dramatically reduce their risk.

Patients will be identified by specialist nurses and clinical pharmacists, who are trained to treat an irregular heart rhythm condition, called atrial fibrillation, which increases the chance of having a stroke.

Some 1,124 patients in North Tyneside have atrial fibrillation, but are not currently being treated with anticoagulation drug therapy.

Dr Lesley Ashton, a local GP and clinical lead at NHS North Tyneside Clinical Commissioning Group (CCG), said: “People with atrial fibrillation are five times more likely to have a stroke so this can make a real difference in preventing strokes, saving lives and helping people avoid severe disability.”

Specialist clinicians will review patients’ records in ‘virtual clinics’, and those at risk will then be invited into their practice to discuss the treatment.

A total of £323,000 has been allocated to support the scheme in North Tyneside.

Virtual clinics will get under way in North Tyneside practice this month until November, with the scheme due to complete by March 2020.

As part of the programme, four practice-based pharmacists in North Tyneside will be trained in shared decision making.

North Tyneside is one of 23 areas in England to introduce this scheme, which aims to treat more than 18,000 people, preventing around 700 strokes, saving an estimated 200 lives and stopping long-term health problems.

If it is successful, the new approach is likely to be rolled out across the whole of England.

The scheme follows another local initiative led by North Tyneside CCG, which is identifying undiagnosed atrial fibrillation patients using ‘AliveCor’ devices.

Supported by the Academic Health Science Network for the North East and North Cumbria, this scheme involves patients placing two fingers on the device, which then generates an ECG (electrocardiogram) test within 30 seconds. The test can then be reviewed by a clinician, with a treatment plan put in place where needed.

People who suffer an atrial fibrillation-related stroke are more likely to die or suffer severe disability than any other type of stroke.